ZURICH (Reuters) - Swiss drugmaker Novartis' first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/Dowp2GW7p-Q/novartis-ceo-feels-heat-on-u-s-generics-cosentyx-drop-idINKBN1HQ0IG
ZURICH (Reuters) - Roche's hemophilia A drug Hemlibra will get an accelerated review by U.S. regulators for use in a new group of patients, a key... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/r7yjAPRbZbs/roches-hemlibra-gets-speedy-fda-review-for-wider-use-idINKBN1HO0ID
ZURICH (Reuters) - Swiss fragrance and flavors company Givaudan has begun recycling Haitian vetiver roots now used to make oil for fragrances to... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/N7YCJswdmos/givaudan-turns-to-haitian-roots-for-anti-wrinkle-ingredient-idINKBN1HN1CQ
ZURICH (Reuters) - Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/VEMrhnTkN1g/lonzas-virus-factory-shows-gene-therapys-texas-sized-promise-idINKBN1HH18I
ZURICH (Reuters) - Novartis is moving further into gene therapy with a $8.7 billion deal for AveXis that gives the Swiss drugmaker a rare-disease... ...http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/l744Ld1A8ts/novartis-bets-big-on-gene-therapy-with-8-7-billion-avexis-deal-idINKBN1HG0KO
A trip to Zurich, the stunning area...
Life in Zurich
Zurich is a global insurer with...
Beautiful Zurich: Photography...